Qualigen Therapeutics IncEigentümerstruktur
| Preis (2026-01-20) | 52W Hoch | 52W Tief |
| 2.33 USD | 6,48 USD | 1,61 USD |
| Analysten Konsens | Buy | Outperform | Hold | Underperform | Sell |
| 5 USD | 1 | 0 | 0 | 0 | 0 |
| #Shares | Short [%] | Short Ratio |
| 2.033.072 | 18,84 | 0,12 |
Eigentümerstruktur
Analyse der Aktionärsstruktur und institutionellen Investoren
Unternehmensdaten
Grundlegende Informationen
Grunddaten
Name Qualigen Therapeutics Inc
Mitarbeiter 0
Handelsplatz NASDAQ
Ticker Symbol QLGN
IPO Datum 2015-06-24
Adresse 5857 Owens Avenue, Carlsbad, CA, United States, 92008
Webseite https://qlgntx.com
Unternehmensführung
| Rang | Name | Position |
|---|---|---|
| 1 | Mr. Kevin A. Richardson II | Co-CEO, Chief Accounting Officer & Chairman of the Board |
| 2 | Mr. Robert W. Campbell Becher | President |
| 3 | Mr. Michael S. Poirier | Chief Operating Officer |
| 4 | Mr. Christopher L. Lotz | VP of Finance & Corporate Secretary |
| 5 | Mr. Jiawei Wang | Co-Chief Executive Officer |
| 6 | Mr. Koti Meka | Chief Financial Officer |
Aktionärsverteilung
Aufteilung der Investoren
Größte Investoren
| Rang | Inhaber | Anteile | Wert |
|---|---|---|---|
| 1 | LLBH Private Wealth Management, LLC | 0,00% | 0,00 Mio. USD |
| 2 | Tower Research Capital LLC | 0,00% | 0,00 Mio. USD |
| 3 | BlackRock Inc | 0,00% | 0,00 Mio. USD |
| 4 | HARBOUR INVESTMENTS, INC. | 0,00% | 0,00 Mio. USD |
| 5 | Group One Trading, LP | 0,00% | 0,00 Mio. USD |
| 6 | U.S. Bancorp | 0,00% | 0,00 Mio. USD |
| 7 | Bank of America Corp | 0,00% | 0,00 Mio. USD |
| 8 | Uma Financial Services Inc | 0,00% | 0,00 Mio. USD |
| 9 | SBI Securities Co Ltd | 0,00% | 0,00 Mio. USD |
| 10 | UBS Group AG | 0,00% | 0,00 Mio. USD |
| 11 | FNY Investment Advisers, LLC | 0,00% | 0,00 Mio. USD |
| 12 | Morgan Stanley - Brokerage Accounts | 0,00% | 0,00 Mio. USD |
| 13 | JPMorgan Chase & Co | 0,00% | 0,00 Mio. USD |
| 14 | Advisor Group Holdings, Inc. | 0,00% | 0,00 Mio. USD |